Innocan Pharma Corporation

Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest

Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest

FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering